Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Wellgistics Health, Inc. (WGRX) had Revenue of $3.01M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$3.01M
Net Income	$-34.32M
Cost of Goods Sold	$2.78M
Gross Profit	$0.23M
Operating Expenses	$34.56M
Operating Income	$-31.55M
Non-Operating Income/Expense	$-2.77M
Pre-Tax Income	$-34.32M
Normalized Pre-Tax Income	$-34.32M
Income after Taxes	$-34.32M
Income from Continuous Operations	$-34.32M
Consolidated Net Income/Loss	$-34.32M
Normalized Income after Taxes	$-34.32M
EBIT	$-31.55M
EBITDA	$-30.34M
Weighted-Average Shares Outstanding (Basic)	74.38M
Weighted-Average Shares Outstanding (Diluted)	74.38M
Earnings per Share (EPS) (Basic)	$-0.46
Earnings per Share (EPS) (Diluted)	$-0.46
Balance Sheet Financials
Current Assets	$12.82M
Property, Plant, and Equipment	$0.27M
Long-Term Assets	$39.96M
Total Assets	$52.78M
Current Liabilities	$32.74M
Long-Term Debt	$12.60M
Long-Term Liabilities	$13.26M
Total Liabilities	$46.00M
Common Equity	$6.78M
Tangible Shareholders Equity	$-27.90M
Shareholders Equity	$6.78M
Common Shares Outstanding	89.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.56M
Cash Flow from Investing Activities	$-0.63M
Cash Flow from Financial Activities	$8.39M
Beginning Cash	$1.03M
End Cash	$4.23M
Increase/Decrease in Cash	$3.20M
Stock-Based Compensation	$54.44M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.39
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.65
Debt to Equity Ratio	4.25
Gross Margin	7.67%
Operating Margin	-1047.11%
EBIT Margin	-1047.11%
EBITDA Margin	--
Pre-Tax Profit Margin	-1139.04%
Profit Margin	-1139.04%
Free Cash Flow	$-5.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.37
Receiveable Turnover	2.74
Days Sales in Receivables	32.84
Return on Equity	-506.32%
Return on Tangible Equity	123.01%
Return on Assets	-65.02%
Return on Investments	-177.10%
Book Value Per Share	$0.08
Free Cash Flow per Share	$-0.07
Operating Cash Flow per Share	$-0.06

Data from Zacks Investment Research, Inc.